1st FDA-Approved Cancer Vaccine
Airtime: Thurs. Apr. 29 2010 | 2:45 PM ET
Shares of Dendreon sharply higher today, with CNBC’s Bertha Coombs.
Similar Posts
Boards vs. Management
Should investors focus on the board instead of the management team of a company? Janice Ellig, co-CEO of executive search firm Chaddick Ellig, shares her insight.
EU Package Won't Cure Countries' Insolvency: Roche
We have a $700 billion to $1 trillion rescue package being thrown at countries “which are patently insolvent,” David Roche from Independent Strategy said Monday. He added that EU leaders have not addressed how the austerity measures are going to be enabled to help these countries become solvent again.
The VC Bright Spot
The VC Bright Spot, It’s a bull market for venture capital, with CNBC’s Julia Boorstin,
Dollar Still Going Up: Charts
The dollar is still going up and has a chance to create a “good top” in the near-term, Bill McLaren, independent trader, said Friday. He also looks at the chart for the S&P 500 index.
World's Safest Banks
Discussing whether U.S. banks are any safer than two years ago, with Joseph Giarraputo, Global Finance Magazine Publisher.
Intel's Q1 Earnings Smash Forecasts
US tech bellwether Intel reported a near quadrupling of profit in the first quarter. It also raised its full-year margins outlook. “We’re delighted with the performance, to see a record Q1 on the back of a tough 2009,” Graham Palmer, UK MD at Intel, said Wednesday. “From a European perspective, we exceeded our expectations.”
